Skip to main content

Clinical trial BSMO 2014 01

A prospective, Belgian multi-center, single-arm, phase II study of neoadjuvant weekly paclitaxel and carboplatin followed by dose dense epirubicin and cyclophosphamide in stage II and III triple negative breast cancer

Organ breast
Trial status Trial open for recruitment
Trial type
Prospective interventional
Phase Trial phase 2
Academic trial Oui
Sponsor BSMO
EudraCT Identifier 2014-003723-21
Inclusion criteria TNBC
Last update